Changeflow GovPing Healthcare & Life Sciences Antiviral agents and uses thereof
Routine Notice Added Final

Antiviral agents and uses thereof

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO granted Patent US12590092B2 to Griffith University for antiviral compounds of Formula (I) and pharmaceutical compositions for treating viral infections. The patent, with 21 allowed claims, names Mark Von Itzstein, Ibrahim El-Deeb, Patrice Guillon, and Larissa Heilig as inventors. Filing date was January 28, 2022.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Griffith University has received US Patent 12590092B2 for antiviral agents comprising compounds of Formula (I) and their uses in treating viral infections. The patent covers pharmaceutical compositions containing these compounds and methods of treatment. The invention relates to heterocyclic, heteroaryl, cycloalkyl, and aryl ring structures with antiviral properties.

Pharmaceutical companies and drug manufacturers should review this patent to assess potential licensing needs or freedom-to-operate concerns for antiviral drug development programs. This is a routine patent grant notification and does not impose new compliance obligations on regulated entities.

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Antiviral agents and uses thereof

Grant US12590092B2 Kind: B2 Mar 31, 2026

Assignee

GRIFFITH UNIVERSITY

Inventors

Mark Von Itzstein, Ibrahim El-Deeb, Patrice Guillon, Larissa Heilig

Abstract

The present invention relates to a compound of Formula (I), or a pharmaceutically acceptable salt thereof:
and to pharmaceutical compositions comprising the compound. In Formula (I), R3 is selected from the group consisting of:

wherein rings W, X, Y and Z may relate to various heterocyclic, heteroaryl, cycloalkyl, cycloalkenyl, and/or aryl rings. The present invention also relates to uses of the compounds in treating a disease, disorder or condition caused by viral infection.

CPC Classifications

A61P 31/16 C07D 471/04 C07D 487/04 C07D 495/04 C07D 487/14 C07D 491/048

Filing Date

2022-01-28

Application No.

18263481

Claims

21

View original document →

Named provisions

Antiviral agents and uses thereof

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12590092B2

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Pharmaceutical Patents Antiviral Drug Development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!